UVA radiation is a major environmental stress on skin, causing acute and chronic photodamage. These responses are mediated by reactive oxygen species (ROS), although the cellular source of these ROS is unknown. We tested the hypotheses that UVA-induced activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is required for ROS generation in human keratinocytes (HK) and that these ROS initiate rapid prostaglandin E 2 (PGE 2 ) synthesis. Treatment of HK with a non-toxic dose of UVA rapidly increased NADPH oxidase activity and intracellular ROS, which were partially blocked by an inhibitor of NADPH oxidase and by a mitochondria-selective antioxidant. Depleting the Nox1 isoform of the catalytic subunit of NADPH oxidase using small interfering RNA (siRNA) blocked the UVA-induced ROS increase, indicating that ROS produced by mitochondria or other sources are downstream from Nox1. Nox1 siRNA also blocked UVA-initiated PGE 2 synthesis. The mechanism for activation of Nox1 is mediated by an increase in intracellular calcium. Ceramide, which has been proposed to mediate responses to UVA in HK, also activated NADPH oxidase. These results indicate that UVA activates Nox1-based NADPH oxidase to produce ROS that stimulate PGE 2 synthesis, and that Nox1 may be an appropriate target for agents designed to block UVA-induced skin injury.
INTRODUCTION
UVA radiation, 320-400 nm, comprises about 95% of the solar UV reaching the earth's surface and initiates multiple responses in skin. Chronic exposure to solar UVA contributes to deleterious effects including skin cancer, tumor promotion, immunosuppression, and photoaging (de Laat et al., 1997; Krutmann, 2001; Bachelor and Bowden, 2004; Allanson et al., 2006) . The role of UVA in development of cutaneous melanoma is still being debated (Setlow et al., 1993; De Fabo et al., 2004; Wood et al., 2006) . Acute responses in normal skin to UVA include rapid erythema and immediate pigment darkening as well as delayed erythema and tanning. Certain photosensitivity conditions are also induced by UVA (Charman et al., 1998) . Beneficial effects of UVA exposure include treatments for cutaneous scleroderma and atopic dermatitis (Krutmann, 2000; Breuckmann et al., 2004) .
Early studies established that UVA-induced erythema and tanning required oxygen in human skin (Auletta et al., 1986) and more recent studies have clearly shown that responses in skin cells to UVA are mediated by reactive oxygen species (ROS). These ROS initiate signal transduction processes leading to rapid synthesis and release of inflammatory mediators, for example, prostaglandin E 2 (PGE 2 ) and isoprostanes, as well as induction of new gene products, for example, heme oxygenase-1, cytokines, cyclooxygenase, ICAM-1 (Grether-Beck et al., 1996 Mahns et al., 2004; Belli et al., 2005) . Despite their fundamental involvement in UVA-induced effects in skin, the types of the ROS responsible for initiating these responses are still unclear. The involvement of singlet oxygen ( (Grether-Beck et al., 1996; Tyrrell, 2000) . Singlet oxygen is formed in cells by energy transfer to molecular oxygen from the triplet excited state of endogeneous chromophores possibly including porphyrins, NAD(P)H, flavins, cytochromes, heme, and other enzyme cofactors. Additional types of ROS are required for UVA-induced responses because 1 O 2 is present only during the irradiation due to its short lifetime in cells (Skovsen et al., 2005; Redmond and Kochevar, 2006) and ROS are detected long after the end of the UVA treatment. Thus, ROS continue to be produced for an extended period and, as ROS quenchers that do not affect 1 Abbreviations: BAPTA-AM, 1,2-bis-(O-aminophenoxy)-ethane-N,N,N 0 ,N 0 -tetraacetic acid, tetraacetoxymethyl ester; [Ca 2 þ ] i , intracellular calcium concentration; carboxy-H 2 DCFDA, 5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate; DPI, diphenylene iodinium; HK, human keratinocytes; MitoQ or MQ, mitochondrially-targeted ubiquinone; PGE 2 , prostaglandin E 2 ; ROS, reactive oxygen species for UVA-induced responses . The extended production of ROS after photosensitization to produce 1 O 2 with an exogeneous dye has been demonstrated (Ouedraogo and Redmond, 2003) . Potential cellular sources of extended production and enhanced levels of ROS include enzymes such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the mitochondrial electron transport chain and oxidation products from the reaction of phox , Rac1) that assemble to produce the active enzyme (Babior et al., 2002) . Recently, homologues of these subunits have been described in several cell types and their activities investigated (Lambeth, 2004) . Human keratinocytes (HK) express the gp91 phox /Nox2 catalytic subunit as well as its homologue, Nox1 (Chamulitrat et al., 2004; He et al., 2005; . Murine keratinocytes express Nox2, although this subunit was shown to be only minimally involved in UVA-induced apoptosis (He et al., 2005) . We have recently shown that UVA irradiation of keratinocytes that are treated to have a high membrane content of 7-dehydrocholesterol (mimicking the UVA photosensitivity disease Smith-Lemli-Optiz syndrome) produce higher levels of ROS and that NADPH oxidase is involved in ROS generation . Whether UVA activates NADPH oxidase in normal keratinocytes has not been examined.
Previous studies have shown that UVA-initiated production of ROS involve mitochondria, as blocking complex I of the electron transport chain in the inner mitochondrial membrane inhibited ROS formation . In addition, UVA has been shown to cause lipid peroxidation in cell membranes (Morliere et al., 1991) , suggesting that ROS produced by chain radical oxidation of unsaturated lipids may also contribute to the extended formation of ROS after UVA.
In this study, we tested the hypotheses that the UVAinduced ROS formation in normal HK require the activation of the Nox1 catalytic subunit of NADPH oxidase and that these ROS stimulate synthesis of PGE 2 that can contribute to immediate and chronic UVA-induced skin responses.
RESULTS
NADPH oxidase is a major source of UVA-induced ROS in keratinocytes
Our previous results indicated that 10 J/cm 2 UVA was not cytotoxic to the same HK as used in this study . In this study, HK were irradiated with 5 J/cm 2 and the relative level of intracellular ROS was quantified as a function of time after irradiation by measuring the fluorescence from the oxidation product of 5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA) (Figure 1) . A significant increase in ROS occurred by 5 minutes after irradiation in irradiated HK compared with non-irradiated controls. A maximum level of ROS was observed at 15 minutes and by 60 minutes the ROS level was only slightly greater than that in the unirradiated cells. Diphenylene iodinium (DPI) is often used as an inhibitor of NADPH oxidase, although it may not be entirely specific for this enzyme (Riganti et al., 2004) . DPI (1 mM) inhibited the UVA-induced level of ROS at 15 minutes by B65%. As mitochondria are a potential source of ROS after UVA irradiation , we used mitochondrially-targeted ubiquinone (MitoQ or MQ), a recycling ubiquinone antioxidant that selectively localizes in mitochondria due to its triphenylphosphonium cation group, although a portion of the MitoQ taken up by cells localizes in non-mitochondrial membranes (Kelso et al., 2001) . The UVA-induced ROS level at 15 minutes was decreased by B30% by 0.1 mM MitoQ, suggesting that ROS arising in mitochondria, and possibly other subcellular membranes, contribute to the ROS observed after UVA treatment, although at a lower level than NADPH oxidase. Neither DPI nor MitoQ alone completely decreased the ROS to that of the unirradiated control. Combining 0.1 mM MitoQ with 1 mM DPI did not produce a greater effect on UVA-induced ROS formation than the 65% reduction observed by DPI alone (results not shown). Higher levels of both agents were also tested (up to 5 mM of MitoQ plus 10 mM of DPI) in order to reduce the ROS level to baseline. However, these combinations resulted in cell death at 6 hours after UVA treatment (results not shown).
As DPI substantially decreased the UVA-induced ROS, the activity of NADPH oxidase was measured in HK as a function of time after UVA treatment. NADPH oxidase, measured as the superoxide dismutase-inhibitable cytochrome c oxidation www.jidonline.org 215 in membrane fractions obtained from cell lysates, was rapidly activated by UVA with a maximum activity at 10 minutes ( Figure 2a ). The activity gradually decreased to the level in unirradiated control cells at 60 minutes after UVA irradiation. The kinetics of UVA-induced NADPH oxidase activity is similar to those for ROS formation ( Figure 1 ). We tested the hypothesis that Nox1, one of the NADPH oxidase catalytic subunits expressed in HK, is the principal source of ROS formed in HK after UVA irradiation. RNA interference was used to knock down the levels Nox1. Two small interfering RNA (siRNA) (Nox1A-siRNA and Nox1B-siRNA) drastically decreased of ROS in UVA-irradiated HK, with nearly complete 100% inhibition of ROS production at 10, 15, and 20 minutes after UVA (Figure 3a ). HK treated with scrambled sequence siRNA produced ROS levels after UVA identical to untreated HK. To assess the extent of that siRNA treatments reduced Nox1 protein, Western blotting was used. Levels of Nox1 using Nox1A-siRNA and Nox1B-siRNA were decreased in 90 and 85%, respectively, and scrambled siRNA did not affect the Nox1 level ( Figure 3b ). Blocking Nox1 protein synthesis by two different siRNA sequences strongly suggests that the observed inhibition of UVA-induced ROS is a Nox1-specific effect rather than a nonspecific effect of the siRNA treatment. The results in Figure 3a also show that Nox1 siRNA reduced the UVA-induced ROS most effectively at shorter times, as by 40 minutes the same ROS level was present in both siRNA-treated and -untreated samples, suggesting another source of ROS at longer times.
UVA increases Nox1-dependent PGE 2 release in HK As UVA provokes a rapid increase in PGE 2 levels in skin, we monitored the release of PGE 2 as a function of time from UVA irradiated HK. PGE 2 release was significantly increased by 10 minutes after UVA, reached a maximum after 30-35 minutes, decreased and then reached another maximum after 120 minutes (Figure 4a) . The PGE 2 level remained greater than the unirradiated control HK for at least 4 hours after UVA irradiation. The UVA-induced increase in PGE 2 release was blocked B70%, compared to non-irradiated HK, by treatment with siRNA (Nox1A and Nox1B) at an early time (10 minutes), at the second maxima (120 minutes), and at the valley in between the maxima (60 minutes) ( Figure 4b ). However, DPI was only B40% effective at reducing UVAinduced PGE 2 released at 60 and 120 minutes. Scrambled siRNA did not show any effect. UVA has been shown to increase intracellular calcium, [Ca 2 þ ] i , in fibroblasts (Maziere et al., 2005) . We measured the effect of pretreatment of HK with the calcium chelator 1,2-bis-(O-aminophenoxy)-ethane-N,N,N 0 ,N 0 -tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) (25 mM) on the UVA-induced activity of NADPH oxidase. As shown in Figure 2b , BAPTA-AM decreased NADPH oxidase by 470%. Next, we evaluated whether UVA induced an increase in [Ca 2 þ ] i using the calcium-sensitive fluorescent probe Calcium Orange. [Ca 2 þ ] i increased rapidly after UVA with a significant increase by 5 minutes and a maximum at 15-20 minutes (Figure 5a) (Figure 5b ). Interestingly, MQ was more effective than the NADPH oxidase inhibitors, reducing the [Ca 2 þ ] i by B55% at 20 minutes (Figure 4b) . Measurements made at an earlier time (10 minutes after UVA) gave similar results except that Nox1 siRNA and MQ were more effective than at 20 minutes, reducing [Ca 2 þ ] i by 60 and 75%, respectively.
Ceramide increases ROS production via NADPH oxidase activation
Ceramides have been shown to enhance ROS levels and activate NADPH oxidase in diverse cell types (Li et al., 2002; Zhang et al., 2003) . In addition, UVA irradiation is reported to induce ceramide production in keratinocytes ( (Figure 6a ), similar to the kinetics for ROS after UVA treatment ( Figure 1a) . A single addition of C6-ceramide induced a sustained high level of ROS for 1 hour that returned to basal levels after 2 hours (data not shown). The NADPH oxidase activity was then measured over the same time course and showed similar kinetics than ROS production ( Figure 6b ). DPI inhibited the ceramide-induced increase in ROS nearly completely ( Figure 6a ) and blocked the increase in NADPH oxidase activity completely (Figure 6b ). In contrast, MitoQ did not significantly alter the ROS or NADPH oxidase level induced by C6-ceramide, suggesting that mitochondrial or other sources of ROS downstream from NADPH oxidase do not participate in the ceramide-induced responses. In toto, these results suggest that ceramide might mediate the UVA-induced increase in NADPH.
DISCUSSION
Although UVA irradiation of cells is known to produce ROS, the intracellular sources of these reactive species are not well characterized and several phases of ROS production may occur. However, these initial species must induce extended production of additional ROS, as ROS are detected for an extended period after UVA exposure (Figure 1 ) .
In this study, we focused on NADPH oxidase and mitochondria as sources for extended ROS production after UVA irradiation and tested whether these ROS are responsible for a rapid response of keratinocytes, namely, the production of PGE 2 . Our initial results using small molecule inhibitors with different selectivities, DPI and MitoQ, indicated that ROS are produced by more than one mechanism, as both inhibitors only partially blocked ROS formation (Figure 1 ). In addition, the time course for UVAinduced NADPH oxidase activity paralleled that for ROS formation (Figure 2a ), suggesting that this redox active enzyme was involved. These results did not allow us to discriminate between concurrent production of ROS from different subcellular sources and sequential generation of ROS from different sources. However, when Nox1 protein was 85-95% depleted, the UVA-induced ROS level was decreased by comparable amounts (Figure 3a) indicating that the production of ROS after UVA requires Nox1 activity and implying that Nox1 activity is upstream of ROS production by mitochondria and other cellular sources. A similar sequence for ROS formation was found during rat cardiac ischemia/ reperfusion injury where angiotensin II-induced activation of NADPH oxidase led to production of a much larger amount of ROS by mitochondria (Kimura et al., 2005) . Mitochondrial ROS can also elicit ROS formation by NADPH oxidase, as serum withdrawal that stimulated production of ROS by mitochondria subsequently, by a phosphatidylinositol 3-kinase-dependent mechanism, induced ROS production by NADPH oxidase (Lee et al., 2006) . These are all examples of the more general phenomenon of ROS-induced ROS formation (Zorov et al., 2000; Kimura et al., 2005) .
The mechanism by which the O 2 À produced by Nox1 elicits further ROS formation in cells may follow more than one pathway. Nox1 is localized in the plasma membrane in most cell types and releases O 2 À to the extracellular space (Lambeth, 2004; Takeya and Sumimoto, 2006) . Dismutation (Liu et al., 2006) . Exogenous H 2 O 2 has also been shown to increase intracellular ROS from endogenous sources (Li et al., 2001; Chernyak et al., 2006 ). An alternative pathway involves products of membrane lipid peroxidation, such as 4-hydroxynonenal, that have been shown to stimulate ROS formation by mitochondria (Landar et al., 2006) . Mitochondria are not necessarily the source of ROS after activation of Nox1. Although MitoQ is concentrated in mitochondria, it also partially distributes to other cell membranes and, consequently, may block lipid peroxidation at non-mitochondrial sites (Kelso et al., 2001; James et al., 2005) . MitoQ acts as a membrane-localized antioxidant with the ubiquinol portion of the MitoQ structure buried in the lipid bilayer where it reacts with hydroperoxy or lipid peroxy radicals to terminate lipid oxidation chain reactions (Kelso et al., 2001; James et al., 2005) . Overall, our results indicate that the primary site for the extended production of ROS after UVA treatment is the Nox1-containing isoform of NADPH oxidase in keratinocytes and that mitochondria, as well as other membranes, may also supply downstream ROS.
The mechanism for activation of Nox1 by UVA irradiation is unknown. Activation of Nox1 requires activation of Rac1 and its translocation to the plasma membrane where it binds to the preassembled complex of Nox1, NoxO1 (''Nox organizer''), and NoxA1 (''Nox activator'') (Park et al., 2004; Ueyama et al., 2006) . Our results suggest two possible mechanisms for the activation of Rac1 by the 1 O 2 formed during UVA irradiation. In one mechanism, 1 O 2 causes an increase in [Ca 2 þ ] i , as shown previously for photosensitization (Kessel et al., 2005) , which leads to activation of NADPH oxidase (Figure 2b ). Nox1 itself is not directly calcium dependent (Lambeth, 2004) but, an increase [Ca 2 þ ] i has been shown to activate Rac (Mehta et al., 2005) . Based on studies in prostate carcinoma cells, the mechanism may involve activation of protein kinase C by Ca 2 þ , subsequent phosphorylation of the Rac inhibitor RhoGDIa, which allows Rac to translocate to the plasma membrane (Price et al., 2003) . Interestingly, the UVA-induced increase in the [Ca 2 þ ] i level (Figure 5b ) was partially inhibited (B35%) by Nox1 siRNA, suggesting a positive feedback process: UVA increases [Ca 2 þ ] i , which activates Nox1 thereby increasing the ROS that stimulate a further increase in [Ca] i . Our studies do not define the source of increased [Ca 2 þ ] i , although the UVA-induced increase is partially blocked (B55%) by MitoQ suggesting Ca 2 þ release from mitochondria. An alternative mechanism for activation of Rac1 by 1 O 2 relies on the rapid release of ceramide after UVA, which has been investigated in keratinocytes (Maziere et al., 2001; Grether-Beck et al., 2005) . Ceramide has been shown to activate Rac1 leading to ROS formation by NADPH oxidase in rat mesangial cells (Yi et al., 2004) . The mechanism for this process has not been established in keratinocytes but may involve ceramide-induced activation of phosphatidylinositol 3-kinase (Barsacchi et al., 2003) , which is a known activator of Rac1 via the guanine nucleotide exchange factor b-Pix (Park et al., 2004) .
The ROS produced by NADPH oxidase are responsible for the UVA-initiated increase in PGE 2 , as depletion of Nox1 protein using siRNA nearly completely blocked this response at both the first (10 minutes) and second maxima (120 minutes) (Figure 4b) . Interestingly, Nox1 siRNA treatment only blocked ROS formation up to 30 minutes post-irradiation (Figure 3a) , suggesting that even the PGE 2 contributing to the maximum at 120 minutes requires Nox1 activity at much shorter times after UVA (o30 minutes). The ROS produced in a Nox1-independent manner at times 430 minutes post-UVA does not appear to influence PGE 2 synthesis. The rapid kinetics of the PGE 2 increase (Figure 4a) correlates with those for the [Ca 2 þ ] i increase (Figure 5a ). These two species are linked by the fact that cytosolic PLA 2 , which cleaves arachidonic acid from membrane phospholipids leading to PGE 2 synthesis, is activated by Ca 2 þ . In summary, UVA treatment stimulates formation of ROS in keratinocytes via a Nox1-based NADPH oxidase. Our results suggest that the mechanism for activation of Nox1 involves UVA-induced increase in [Ca 2 þ ] i and ceramide, presumably resulting from initial formation of 1 O 2 , that lead to activation of Rac1. The ROS formed initiate production of additional ROS from oxidation of mitochondrial and possibly other membranes and induce synthesis of PGE 2 , an inflammatory mediator after UVA irradiation, by a Ca 2 þ -dependent mechanism. The role of these ROS in additional UVAinduced responses in keratinocytes requires further study. These results suggest that agents that inhibit the Nox1-containing isoform of NADPH oxidase might block UVAinduced skin injury. Such agents would need to be specific for Nox1 to prevent interfering with the activity and potentially beneficial effects of the phagocyte Nox2-containing isoform of this enzyme.
MATERIALS AND METHODS

Culture of HK
HK immortalized by expression of the catalytic subunit of telomerase were a gift from Dr James Rheinwald (NIH Harvard Skin Disease Research Center). Cells were plated in serum-free keratinocyte medium with phenol red (Gibco Invitrogen, Carlsbad, CA) supplemented with recombinant EGF (2.5 mg/500 ml from Gibco, Invitrogen), bovine pituitary extract (25 mg/500 ml, Gibco), 0.3 mM CaCl 2 , 50 mg streptomycin, and 50,000 U of penicillin per 500 ml of media (Sigma, St Louis, MO). HK were incubated at 371C, 5% CO 2 and medium was replaced every 48 hours until the cells reached 50-60% confluence.
UVA irradiation
The fluorescent UVA broadband lamps (320-420 nm, PUVA 180; Herbert Waldman, Werk fü r lichtechnik Schwenningen, Germany) used had an irradiance of 5.1 mW/cm 2 . Cells were irradiated in Hank's balanced salt solution after removing the culture plate lids and the temperature remained B321C. Immediately after irradiation medium was replaced with fresh serum-free keratinocyte medium or the appropriate treatment medium.
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Detection of ROS
Cells grown in 12-and 6-multiwell plates were incubated for 30 minutes at 371C with 5 mM of carboxy-H 2 DCFDA (Molecular Probes Inc., Molecular Probes Invitrogen, Carlsbad, CA) in Hank's balanced salt solution and irradiated with 5 J/cm 2 UVA (B15 minutes exposure). For ROS measurements at 60 minutes and longer times, carboxy-H 2 DCFDA was added after UVA irradiation, keeping the incubation time at 30 minutes before measurements. After UVA irradiation, the fluorescence was detected using a dual scanning microplate spectrofluorometer (Spectra MAX Gemini EM, Molecular Devices, Sunnyvale, CA) with 480 nm excitation and 530 nm emission.
Preparation of cell fractions and NADPH oxidase activity assay
The isolation of cellular membranes and the NADPH oxidase activity measurements were carried out as described previously . Briefly, cellular homogenates from 3 Â 10 6 cells per sample were obtained in lysis buffer (eight parts of 150 mM K, Na phosphate buffer pH 7.4, 1 mM MgCl 2 , 1 mM EGTA, 2 mM NaN 3 , 1 mM dithiothreitol, and two parts of glycerol containing 50 mM octylglycoside). Post-nuclear fraction was discarded after centrifuged the lysate at 1000 r.p.m. for 10 minutes at 41C. Supernatant was centrifuged at 25 000 r.p.m. in a Beckman Coulter Optima TM L-90K Ultracentrifuge using a NVT 90 rotor for 1 hour at 41C. The pellet was recovered in resuspension buffer (65 mM K, Na phosphate buffer pH 7.4, 1 mM MgCl 2 , 1 mM EGTA, 2 mM NaN 3 , 1 mM dithiothreitol, 20 mg/ml leupeptin, 10 mg/ml pepstatin A, 10 mg/ml aprotinin, and 2 mM phenylmethylsulfonyl fluoride) and used as the membrane fraction. The supernatant was centrifuged at 65 000 r.p.m. using the NVT 90 rotor for 1 hour at 41C. The supernatant cytosolic fraction was used for determination of NADPH oxidase activity. Protein content was determined by Bradford assay.
The superoxide dismutase-inhibitable activity of NADPH oxidase was determined by ferricytochrome c reduction in octylglycosidecontaining buffer (Shpungin et al., 1989) . Twenty and sixty micrograms of protein, respectively, from membrane and cytosolic fractions were incubated in the reaction mixture (0.1 mM cytochrome c, 65 mM K, Na phosphate buffer pH 6.8, 2 mM EGTA, 1 mM MgCl 2 , and 10 mM flavin adenosine dinucleotide) plus 100 mM of SDS for 2 minutes at 241C. Then, superoxide anion production from NADPH oxidase complex was induced by addition of 0.2 mM of NADPH. The absorbance of reduced cytochrome c was measured at 550 nm using a spectrophotometer (Aglient 8453 UV-visible Spectroscopy System, Aglient Technologies, Foster City, CA). Results are expressed as absorbance of cytochrome c reduced at 550 nm.
Silencing Nox1 by RNA interference
Silencing Nox1 experiments were carried out following the protocol described in a previous study Optimal transfection efficiency by the amounts of transfection reagent (Lipofectamine-2000 TM from Invitrogen TM Life Technologies), siRNA, cell density, and the length of exposure of cells to Lipofectmanie2000 TM -siRNA complexes were optimized in our previous study . Briefly, at 24 hours before transfection, HK were transferred onto six-well plates (8 Â 10 5 cells/well) and transfected with 100 nM of each Stealth TMsiRNA duplex using Lipofectamine-2000 TM transfection reagent for 4 hours in serum-reduced media (OptiMem from Gibco Invitrogen) without antibiotics. Then, complete serum-free keratinocyte medium was added to the HK. Maximum levels of transfection were observed at 48 hours with both Nox1-A and Nox1-B primers. Transfection efficiency was monitored by flow cytometry based on FAM-labeled transfected cells, resulted in 75% transfection efficiency with Nox1-A Stealth TM -siRNA and 70% with Nox1-B Stealth TM -siRNA. Cell death was measured by flow cytometry using 7-amino-actinomicyn D, an early apoptotic marker that intercalates in the DNA of apoptotic cells, resulting in 9 and 13% cell death for Nox1-A and Nox1-B, respectively.
Prostaglandin E 2 release PGE 2 release was assayed using a commercial EIA kit (Cayman Chemical; Ann Arbor, MI). The PGE 2 release was detected by the absorption of 5-thio-2-nitrobenzoic acid at 412 nm, which is the product of non-enzymatic reaction between PGE 2 -acetylcholinesterase and acetylthiolcholine plus 5-5 0 -dithio-bis-(2-nitrobenzoic acid).
For these experiments, six-well plates were used containing B400 000 cells at 80% confluence. Results are express as a picogram of PGE 2 released per cell.
Intracellular calcium levels
Intracellular calcium was measured using the fluorescent probe Calcium Orange TM -AM from Molecular Probes Inc. Cells in six-well plates (B520 000 per sample) were incubated with 10 mM of Calcium Orange TM -AM for 30 minutes at 371C. Then the fluorescence was detected in a dual scanning microplate spectrofluorometer (Spectra MAX Gemini EM, Molecular Devices) using 530 nm excitation and 575 nm emission wavelengths. To obtain the total free [Ca 2 þ ] i in the samples, the following formula was applied:
when K d is the dissociation constant for Calcium Orange TM (185 nM), F is fluorescence of experimental samples, F min is the fluorescence in the absence of calcium and F max is the fluorescence of calciumsaturated probe. Calibration was carried out using ionomicyn (1 mM in DMSO; Molecular Probes Inc.) and BAPTA-AM (5 mM 1 hour preincubation; Molecular Probes Inc.).
Immunoblots
Cells homogenates were obtained in lysis buffer (250 mM Tris-HCl pH 6.8, 150 mM NaCl, 4% (w/v) SDS, 0.5 mM EGTA, 5 mM dithio-
